UNSPSC 51292007: Melitracen

This classification denotes an anthracene and tricyclic antidepressive agent with the molecular formula C21H25N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q7T0Y1109Z, chemically known as 3-(10,10-dimethyl-9(10h)-anthracenylidene)-n,n-dimethyl-1-propanamine but generally known as melitracen, which bears US NIH Compound Identifier 25382. European Medicines Agency schedules Melitracen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08725MIG.

UNSPSC 51292007 Melitracen, a Commodity code, does not align with the state and local procurement activity currently tagged to it. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023—seeks procurement of naloxone and safe drug deactivation systems, not melitracen (an antidepressant pharmaceutical). The mismatch between the code's nominal scope and the actual solicitation suggests either a tagging error in the source data or that this code sees minimal relevant state and local procurement activity.

Seminole County's bid calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB requires electronic submission through the county's e-Procurement Portal, drug-free workplace and E-Verify compliance, standard insurance coverages, and a two-year initial term with a one-year renewal option. Potential FEMA funding introduces federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations are noted. Based on the available data, this Commodity code does not represent an active procurement category for state and local governments pursuing melitracen or related pharmaceuticals.